| Full Name | Marissa Boxall |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 500 W Fort St, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669069985 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN-13640 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marissa Boxall, 500 W Fort St, Boise, ID 83702-4501 Ph: (208) 422-1000 | Marissa Boxall, 500 W Fort St, Boise, ID 83702-4501 Ph: (208) 422-1000 |
News Archive
A majority of parents say they are "very" concerned about the amount of sex (60%) and violence (53%) their children are exposed to on TV
The American Academy of Dermatology today reiterated the safety and effectiveness of sunscreens to protect against the damaging effects from exposure to ultraviolet (UV) radiation. As one component of a daily sun-protection strategy, sunscreen is an important tool in the fight against skin cancer, including melanoma, the deadliest form of skin cancer.
Morbid obesity affects the liver: Almost one-third of all adults suffer from chronic fatty liver disease, which can lead to infections and even trigger cancer. Researchers at the University Children's Hospital Zurich and the University of Zurich have now found a signaling pathway in cells that play an important role in the development of fatty liver disease.
ast week's burst of world disorder was ideal for a news dump, and the White House didn't disappoint: On no legal basis, all 4.5 million residents of the five U.S. territories were quietly released from ObamaCare.
Orexigen® Therapeutics, Inc. announced that results from its COR-I trial of Contrave® were published online today in the journal Lancet. COR-I was the largest of the four, 56-week, Phase 3 trials supporting the New Drug Application for Contrave, currently under review by the U.S. Food and Drug Administration. Results show that patients taking Contrave were two to three times more likely to lose at least 5% or 10% of their body weight compared to those taking placebo, on both an intent-to-treat (ITT) and completers basis.
› Verified 3 days ago
James Hd Hecht, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1536 | |
Mr. Brian Lynn Lambrecht, NURSE Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Mandie Marie Phillips, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1051 | |
Ms. Jackie Lynn Rehnstrom, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Harjit Kaur Gala, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Rodney D Mcalpin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Briana Rae Budell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort Steet, Building 28 Room G05, Boise, ID 83702 Phone: 208-422-1000 |